Apimeds Pharmaceuticals is a clinical-stage biopharmaceutical company developing Apitox, an intradermally administered bee venom-based toxin with diverse therapeutic potential.
Apimeds Pharmaceuticals is a clinical-stage biopharmaceutical company developing Apitox, an intradermally administered bee venom-based toxin with diverse therapeutic potential.